{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:40:58Z","timestamp":1775522458529,"version":"3.50.1"},"reference-count":70,"publisher":"FapUNIFESP (SciELO)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Soc. Bras. Med. Trop."],"DOI":"10.1590\/0037-8682-0148-2015","type":"journal-article","created":{"date-parts":[[2015,8,19]],"date-time":"2015-08-19T22:49:31Z","timestamp":1440024571000},"page":"445-453","source":"Crossref","is-referenced-by-count":12,"title":["Efficacy and tolerability of two single-day regimens of triclabendazole for fascioliasis in Peruvian children"],"prefix":"10.1590","volume":"48","author":[{"given":"Vicente","family":"Maco","sequence":"first","affiliation":[{"name":"Cayetano Heredia University, Peru"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Marcos","sequence":"additional","affiliation":[{"name":"Cayetano Heredia University, Peru"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaime","family":"Delgado","sequence":"additional","affiliation":[{"name":"Asillo Az\u00e1ngaro, Peru"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julio","family":"Herrera","sequence":"additional","affiliation":[{"name":"Health Care Center of Canta, Peru"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Nestares","sequence":"additional","affiliation":[{"name":"Health Care Center of Canta, Peru"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelica","family":"Terashima","sequence":"additional","affiliation":[{"name":"Cayetano Heredia University, Peru"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frine","family":"Samalvides","sequence":"additional","affiliation":[{"name":"Cayetano Heredia University, Peru"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"Gotuzzo","sequence":"additional","affiliation":[{"name":"Cayetano Heredia University, Peru"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","published-online":{"date-parts":[[2015,8]]},"reference":[{"key":"ref1","first-page":"340","article-title":"Epidemiology of human fascioliasis: a review and proposed new classification","volume":"77","author":"Mas-Coma MS","year":"1999","journal-title":"Bull World Health Organ"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1079\/JOH2005296","article-title":"Epidemiology of fascioliasis in human endemic areas","volume":"79","author":"Mas-Coma S","year":"2005","journal-title":"J Helminthology"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.ijpara.2005.07.010","article-title":"Fascioliasis and other plant-borne trematode zoonoses","volume":"35","author":"Mas-Coma S","year":"2005","journal-title":"Int J Parasitol"},{"key":"ref4","first-page":"389","article-title":"Fasciola hepatica infection in Peru: an emergent disease","volume":"27","author":"Marcos LA","year":"2007","journal-title":"Rev Gastroenterol Peru"},{"key":"ref5","first-page":"231","article-title":"An investigation of endemic fascioliasis in Peruvian village children","volume":"76","author":"Stork MG","year":"1973","journal-title":"J Trop Med Hyg"},{"key":"ref6","first-page":"158","article-title":"Hyperendemicity of human fasciolosis in the Mantaro Valley, Peru: factors for infection with Fasciole hepatica","volume":"24","author":"Marcos LA","year":"2004","journal-title":"Rev Gastroenterol Peru"},{"key":"ref7","first-page":"50","author":"S\u00e1nchez C","year":"1993"},{"key":"ref8","first-page":"42","article-title":"Human fascioliasis: prevalence and treatment in a rural area of Peru","volume":"2","author":"Ortiz P","year":"2000","journal-title":"Infect Dis Rev"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1590\/S1726-46342010000400018","article-title":"Human and animal fascioliasis in Peru: impact in the economy of endemic zones","volume":"27","author":"Espinoza JR","year":"2010","journal-title":"Rev Peru Med Exp Salud Publica"},{"key":"ref10","first-page":"31","article-title":"Zonas Hiperend\u00e9micas y Mesoend\u00e9micas de la Infecci\u00f3n por Fasciola hep\u00e1tica aleda\u00f1as a la Ciudad de Lima: una Enfermedad Emergente","volume":"27","author":"Marcos L","year":"2007","journal-title":"Rev Gastroenterol Peru"},{"key":"ref11","author":"Zegarra N","year":"1964"},{"key":"ref12","first-page":"193","article-title":"Edmundo Escomel: 1880-1959","volume":"23","author":"Naquira C.","year":"2006","journal-title":"Acta Med Per"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1001\/jama.1967.03130150117030","article-title":"Diagnosis and treatment of human fascioliasis","volume":"202","author":"Hadden JW","year":"1967","journal-title":"JAMA"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1136\/bmj.3.5721.500","article-title":"Human fascioliasis in Shropshire","volume":"3","author":"Ashton WL","year":"1970","journal-title":"Br Med J"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1136\/bmj.3.5721.502","article-title":"Fascioliasis--a large outbreak","volume":"3","author":"Hardman EW","year":"1970","journal-title":"Br Med J"},{"key":"ref16","first-page":"385","article-title":"Epidemic human fascioliasis. Cuba 1983. VI. Clinical study of 40 children in the Hospital Provincial of Sagua la Grande","volume":"44","author":"Diaz J","year":"1990","journal-title":"G e N"},{"key":"ref17","first-page":"240","article-title":"Bithionol (Bitin) treatment in established fascioliasis in Egyptians","volume":"91","author":"Farag HF","year":"1988","journal-title":"J Trop Med Hyg"},{"key":"ref18","first-page":"514","article-title":"Fasciola hepatica infestation. Biopathology and new diagnostic and therapeutic aspects","volume":"10","author":"Gorgolas M","year":"1992","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/clinids\/17.3.426","article-title":"Fascioliasis: case reports and review","volume":"17","author":"Price TA","year":"1993","journal-title":"Clin Infect Dis"},{"key":"ref20","first-page":"65","article-title":"Fascioliasis hep\u00e1tica: Un nuevo caso en la infancia","volume":"50","author":"Garc\u00eda ML","year":"1999","journal-title":"An Esp Pediatr"},{"key":"ref21","first-page":"88","article-title":"Human fascioliasis in Cajamarca\/Peru. I. Diagnostic methods and treatment with praziquantel","volume":"36","author":"Knobloch J","year":"1985","journal-title":"Trop Med Parasitol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1093\/infdis\/152.6.1339","article-title":"Successful treatment of severe infection with Fasciola hepatica with praziquantel","volume":"152","author":"Schiappacasse RH","year":"1985","journal-title":"J Infect Dis"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1093\/infdis\/154.5.920","article-title":"Unsuccessful use of praziquantel to treat acute fascioliasis in children","volume":"154","author":"Farid Z","year":"1986","journal-title":"J Infect Dis"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S1383-5769(02)00004-1","article-title":"A praziquantel-ineffective fascioliasis case successfully treated with triclabendazole","volume":"51","author":"Ishii Y","year":"2002","journal-title":"Parasitol Int"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/0035-9203(90)90060-R","article-title":"Praziquantel and Fasciola hepatica infection","volume":"84","author":"Ripert CL","year":"1990","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref26","first-page":"179","article-title":"Metronidazole in fascioliasis: report of four cases","volume":"80","author":"Nik-Akhtar B","year":"1977","journal-title":"J Trop Med Hyg"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/0016-5085(81)90510-2","article-title":"Treatment of human fascioliasis with niclofolan","volume":"81","author":"Eckhardt T","year":"1981","journal-title":"Gastroenterology"},{"key":"ref28","first-page":"497","article-title":"The effect of triclabendazole (Fasinex) in children with fasciolosis","volume":"28","author":"Yilmaz H","year":"1998","journal-title":"J Egypt Soc Parasitol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1445-5994.1992.tb01708.x","article-title":"Human fascioliasis successfully treated with triclabendazole","volume":"22","author":"Laird PP","year":"1992","journal-title":"Aust N Z J Med"},{"key":"ref30","article-title":"Fascioliasis and intestinal parasitoses affecting schoolchildren in atlixco, puebla state, Mexico: epidemiology and treatment with nitazoxanide","volume":"7","author":"Zumaquero-Rios JL","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1046\/j.1365-2036.2003.01419.x","article-title":"Double-blind, randomized, placebo-controlled study of nitazoxanide in the treatment of fascioliasis in adults and children from northern Peru","volume":"17","author":"Favennec L","year":"2003","journal-title":"Alimentary Pharmacol Ther"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/0035-9203(88)90222-2","article-title":"Human fascioliasis treated with triclabendazole (Fasinex) for the first time","volume":"82","author":"Wessely K","year":"1988","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref33","first-page":"1048","article-title":"Fasciola hepatica infection. Successful therapy using triclabendazole","volume":"118","author":"Markwalder K","year":"1988","journal-title":"Schweiz Med Wochenschr"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1517\/13543784.14.12.1513","article-title":"Triclabendazole for the treatment of fascioliasis and paragonimiasis","volume":"14","author":"Keiser J","year":"2005","journal-title":"Expert Opin Investig Drugs"},{"key":"ref35","year":"2011"},{"key":"ref36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001720","article-title":"Administration of triclabendazole is safe and effective in controlling fascioliasis in an endemic community of the Bolivian Altiplano","volume":"6","author":"Villegas F","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"977","DOI":"10.4269\/ajtmh.2007.76.977","article-title":"Evaluation of Fas2-ELISA for the serological detection of Fasciola hepatica infection in humans","volume":"76","author":"Espinoza JR","year":"2007","journal-title":"Am J Trop Med Hyg"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.trstmh.2005.05.016","article-title":"Risk factors for Fasciola hepatica infection in children: a case-control study","volume":"100","author":"Marcos L","year":"2006","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref39","first-page":"167","article-title":"Acerca de un procedimiento de sedimentaci\u00f3n r\u00e1pida para investigar huevos de Fasciola hepatica en las heces, su evaluaci\u00f3n y uso en el campo","volume":"31","author":"Lumbreras H","year":"1962","journal-title":"Rev Medica Peruana"},{"key":"ref40","first-page":"397","article-title":"A simple device for quantitative stool thick-smear technique in Schistosomiasis mansoni","volume":"14","author":"Katz N","year":"1972","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/17843286.1992.11718231","article-title":"Distomatosis of the bile ducts. Value of retrograde cholangiography. Efficacy of triclabendazole","volume":"47","author":"De Ronde T","year":"1992","journal-title":"Acta Clin Belg"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1046\/j.1365-2125.1998.00725.x","article-title":"Effect of food on the bioavailability of triclabendazole in patients with fascioliasis","volume":"45","author":"Lecaillon JB","year":"1998","journal-title":"Br J Clin Pharmacol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"49","DOI":"10.20453\/rmh.v13i2.722","article-title":"Fas2-ELISA y la t\u00e9cnica de sedimentaci\u00f3n r\u00e1pida modificada por Lumbreras en el diagn\u00f3stico de la infecci\u00f3n por Fasciola hepatica","volume":"13","author":"Maco V","year":"2002","journal-title":"Rev Med Hered"},{"key":"ref44","first-page":"137","article-title":"Therapeutic effect of triclabendazole in patients with fascioliasis in Egypt. A preliminary study","volume":"25","author":"Hammouda NA","year":"1995","journal-title":"J Egypt Soc Parasitol"},{"key":"ref45","first-page":"89","article-title":"Clinical trial of triclabendazole on human fascioliasis: Long term follow up","volume":"13","author":"Yadegari D","year":"1999","journal-title":"Med J Islamic Rep Iran"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"264","DOI":"10.4269\/ajtmh.2000.63.264","article-title":"The efficacy and tolerability of triclabendazole in Cuban patients with latent and chronic Fasciola hepatica infection","volume":"63","author":"Millan JC","year":"2000","journal-title":"Am J Trop Med Hyg"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1440-1681.2004.04093.x","article-title":"Randomized trial of a single, double and triple dose of 10 mg\/kg of a human formulation of triclabendazole in patients with fascioliasis","volume":"31","author":"Talaie H","year":"2004","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.3855\/jidc.5124","article-title":"Fasciola hepatica infection at a University Clinic in Turkey","volume":"8","author":"Ulger BV","year":"2014","journal-title":"J Infect Dev Ctries"},{"key":"ref49","first-page":"51","article-title":"Pediatric fascioliasis: report of three cases","volume":"45","author":"Kabaalioglu A","year":"2003","journal-title":"Turk J Pediatr"},{"key":"ref50","first-page":"216","article-title":"Tratamiento de la Fasciolasis Hep\u00e1tica Humana con Triclabendazole","volume":"19","author":"Jave JA","year":"1999","journal-title":"Rev Gastroenterol Peru"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S1695-4033(02)78694-3","article-title":"Tratamiento con triclabendazol en la fasciolasis hep\u00e1tica infantil","volume":"57","author":"Iglesias Escalera G","year":"2002","journal-title":"An Esp Pediatr"},{"key":"ref52","first-page":"362","article-title":"Fasciola hepatica infection: clinical and radiological findings in pediatric patients","volume":"54","author":"Karadag-Oncel E","year":"2012","journal-title":"Turk J Pediatr"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"532","DOI":"10.4269\/ajtmh.1995.52.532","article-title":"Treatment of human chronic fascioliasis with triclabendazole: drug efficacy and serologic response","volume":"52","author":"Apt W","year":"1995","journal-title":"J Trop Med Hyg"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/tropej\/45.3.135","article-title":"Human fascioliasis in Egyptian children: successful treatment with triclabendazole","volume":"45","author":"El-Karaksy H","year":"1999","journal-title":"J Trop Pediatrics"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"888","DOI":"10.26719\/1999.5.5.888","article-title":"Triclabendazole in the treatment of human fascioliasis: a community-based study","volume":"5","author":"el-Morshedy H","year":"1999","journal-title":"East Mediterr Health J"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s11096-006-9069-8","article-title":"Effect of Fascioliasis on the pharmacokinetic parameters of triclabendazole in human subjects","volume":"29","author":"El-Tantawy WH","year":"2007","journal-title":"Pharm World Sci"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"388","DOI":"10.4269\/ajtmh.2008.78.388","article-title":"A randomized controlled pilot study of artesunate versus triclabendazole for human fascioliasis in central Vietnam","volume":"78","author":"Hien TT","year":"2008","journal-title":"Am J Trop Med Hyg"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S0035-9203(98)90919-1","article-title":"Treatment of human pulmonary paragonimiasis with triclabendazole: clinical tolerance and drug efficacy","volume":"92","author":"Calvopina M","year":"1998","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1046\/j.1365-3156.1999.00482.x","article-title":"Fascioliasis: sonographic abnormalities of the biliary tract and evolution after treatment with triclabendazole","volume":"4","author":"Richter J","year":"1999","journal-title":"Trop Med Int Health"},{"key":"ref60","first-page":"11","article-title":"Sonographic Findings of Human Fascioliasis","volume":"4","author":"Mansour Ghanaei F","year":"2006","journal-title":"Iran J Radiol"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1055\/s-2008-1062400","article-title":"Fasciola hepatic infection in a family: diagnosis and therapy","volume":"117","author":"Bechtel U","year":"1992","journal-title":"Dtsch Med Wochenschr"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0140-6736(89)90557-6","article-title":"Single treatment of invasive fascioliasis with triclabendazole","volume":"2","author":"Loutan L","year":"1989","journal-title":"Lancet"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/BF02098098","article-title":"A new report of triclabendazole efficacy during invading phase fasciolasis","volume":"11","author":"Picot S","year":"1992","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref64","first-page":"477","article-title":"Traitement de la Fasciolose humaine par le Triclabendazole","volume":"18","author":"Le Bras M","year":"1989","journal-title":"Med Chir Dig"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1590\/S0036-46651996000100013","article-title":"Hepatic fascioliasis: case report and review","volume":"38","author":"Abdul-Hadi S","year":"1996","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"ref66","first-page":"28","article-title":"Fasciolasis humana con presentacion atipica y grave. Tratamiento con triclabendazol","volume":"16","author":"Merino J","year":"1998","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s100960050338","article-title":"Successful Treatment of Human Fascioliasis with Triclabendazole","volume":"18","author":"L\u00f3pez-V\u00e9lez R","year":"1999","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref68","first-page":"333","article-title":"The treatment of human fascioliasis with triclabendazole","volume":"199","author":"Caminal Montero L","year":"1999","journal-title":"Rev Clin Esp"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/320870","article-title":"Imported Fasciola hepatica infection in the United States and treatment with triclabendazole","volume":"33","author":"Graham CS","year":"2001","journal-title":"Clin Infect Dis"},{"key":"ref70","first-page":"438","author":"Massoud J","year":"1990"}],"container-title":["Revista da Sociedade Brasileira de Medicina Tropical"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/rsbmt\/v48n4\/1678-9849-rsbmt-48-04-00445.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T17:39:56Z","timestamp":1653068396000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0037-86822015000400445&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":70,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2015,8]]}},"alternative-id":["S0037-86822015000400445"],"URL":"https:\/\/doi.org\/10.1590\/0037-8682-0148-2015","relation":{},"ISSN":["1678-9849","0037-8682"],"issn-type":[{"value":"1678-9849","type":"electronic"},{"value":"0037-8682","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]}}}